Matinas BioPharma Holdings (MTNB) EPS (Basic) (2013 - 2026)
Matinas BioPharma Holdings (MTNB) reported EPS (Basic) of -$0.3 for Q1 2026, up 9.09% year-over-year from -$0.28 in Q1 2025, and down 15.38% quarter-over-quarter from -$0.26 in Q4 2025.
Matinas BioPharma Holdings (MTNB) EPS (Basic) (2013 - 2026) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has 14 years of EPS (Basic) data on file, last reported at -$0.3 in Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$0.3, up 9.09% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.99 (up 50.37% YoY), and the FY2025 annual result was -$2.0, up 59.84% from the prior year.
- EPS (Basic) fell to -$0.3 in Q1 2026 per MTNB's latest filing, from -$0.26 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.02 in Q4 2022 and troughed at -$1.68 in Q4 2024.
- A 5-year average of -$0.6 and a median of -$0.33 in 2025 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2023 and 2025: EPS (Basic) sank 6000.0% in 2023, then surged 84.52% in 2025.
- A 5-year view of EPS (Basic) shows it stood at -$0.02 in 2022, then slumped by 6000.0% to -$1.22 in 2023, then plunged by 37.7% to -$1.68 in 2024, then surged by 84.52% to -$0.26 in 2025, then declined by 15.38% to -$0.3 in 2026.
- Business Quant data shows MTNB's EPS (Basic) at -$0.3 in Q1 2026, -$0.26 in Q4 2025, and -$0.4 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - | -0.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.30 |
| Dec 31, 2025 | -0.26 |
| Sep 30, 2025 | -0.40 |
| Jun 30, 2025 | -1.03 |
| Mar 31, 2025 | -0.33 |
| Dec 31, 2024 | -1.68 |
| Sep 30, 2024 | -0.85 |
| Jun 30, 2024 | -1.15 |
| Mar 31, 2024 | -1.34 |
| Dec 31, 2023 | -1.22 |
| Sep 30, 2023 | -1.39 |
| Jun 30, 2023 | -0.03 |
| Mar 31, 2023 | -0.03 |
| Dec 31, 2022 | -0.02 |
| Sep 30, 2022 | -0.03 |
| Jun 30, 2022 | -0.03 |
| Mar 31, 2022 | -0.03 |
| Dec 31, 2021 | -0.03 |
| Sep 30, 2021 | -0.03 |
| Jun 30, 2021 | -0.02 |